Neurology Letters
Patient monitoring during treatment with natalizumab (ORP-24)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zohreh Abna
New Technological Approach to Physical Therapy in Patients with Multiple Sclerosis (ORP-25)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Hassan Azarsa
EEG Patterns in MS-related epilepsy A literature Review (ORP-26)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Reza Najafi
Epidemiological view of national MS registry in Iran (NMSRI) (ORP-27)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sharareh Eskandarieh
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Payere; Mohammad-Ali Nahayati; Soheil Shokri Shakib
Gut-Brain axis and MS: Is this true? (ORP-29)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Morteza Saeidi
Multiple sclerosis and viral hepatitis (ORP-30)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Raika Jamali
Lower urinary tract dysfunction in Multiple Sclerosis, Updates (ORP-31)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Shekoofeh Alaie
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Yazdan Panah; Yousef Mokary; Arshia Ghalamkari; Ahmad Pourmohammadi; Saba Naghavi; Iman Adibi; Fereshteh Ashtari
Effect of eight weeks of respiratory muscle training on respiratory capacity, functional capacity, and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis (ORP-33)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Abolhasani; Shima Ghannadi
Multiple sclerosis and legal medicine (ORP-34)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammadreza Motamed
Optic neuritis and autoimmune optic neuropathies (ORP-35)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Samira Navardi
Treatment approach in Autoimmune encephalitis (ORP-36)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammadali Nahayati
Effect of dynamic neuromuscular stabilization on fatigue and spasticity in people with multiple sclerosis: a randomized controlled trial (ORP-37)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Laleh Abadi Marand
MS Variants (ORP-38)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ebrahim Kouchaki
Multiple sclerosis, infectious and Gastrointestinal complications (ORP-39)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hora Heidari
Multiple sclerosis, Pregnancy, Breastfeeding (ORP-40)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hora Heidari
Patients monitoring during treatment with Teriflunomide (ORP-41)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nahid Hoseini Nejad Mir
The Role of Advanced MRI Techniques and Artificial Intelligence-based Methods In Diagnosis of Multiple Sclerosis (ORP-42)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Vahid Shahmaei
How to estimate the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis? (ORP-43)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sepideh Paybast
Update on inflammation, neurodegeneration and immunoregulation in MS (ORP-44)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mehran Ghaffari
Treatment escalation vs early high efficacy treatment in multiple sclerosis (cons and pros) (ORP-45)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Baghbanian
Nutritional recommendations in multiple sclerosis patients: a narrative review (ORP-46)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nasim Rezaeimanesh
Ophthalmology in multiple sclerosis (ORP-47)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Masoud Aghsaeifard
Paroxysmal Events in Multiple Sclerosis (MS); Pseudoathetosis as a Presenting Symptom of MS (ORP-48)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ahmad Chitsaz
)